MaxLinear, Inc. to Present at Upcoming Financial Conferences
Aug 26, 2016 12:30 pm UTC| Business
CARLSBAD, Calif., Aug. 26, 2016 -- MaxLinear, Inc. (NYSE:MXL), a leading provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and...
STARTEK to Present at the 5th Annual Liolios Gateway Conference on September 8, 2016
Aug 26, 2016 12:30 pm UTC| Business
GREENWOOD VILLAGE, Colo., Aug. 26, 2016 -- StarTek, Inc. ("STARTEK") (NYSE:SRT), a provider of business process outsourcing services, has been invited to present at the 2016 Liolios Gateway Conference being held...
PositiveID Completes Acquisition of Thermomedics and the Caregiver Non-Contact Thermometer
Aug 26, 2016 12:30 pm UTC| Business
DELRAY BEACH, Fla., Aug. 26, 2016 -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it has completed its acquisition...
Aug 26, 2016 12:00 pm UTC| Business
NEW YORK, Aug. 26, 2016 -- TG Therapeutics, Inc.(NASDAQ:TGTX) today announced that theU.S. Food and Drug Administration(FDA) has granted orphan drug designation for TG-1101 (ublituximab) the Company’s novel,...
MediWound to Present at 11th Annual Wells Fargo Healthcare Conference
Aug 26, 2016 12:00 pm UTC| Business
YAVNE, Israel, Aug. 26, 2016 -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that Company...
WGE Holdings Acquires Additional Indonesian Mining Site
Aug 26, 2016 12:00 pm UTC| Business
LOS ANGELES, Aug. 26, 2016 -- WGE Holdings Corp. (OTC:WGEE) today announced it has acquired an additional site to be operated in conjunction with its existing gold mining properties in Northern Indonesia. The newly...
Aug 26, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 26, 2016 -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today announced that interim results from its ongoing Phase 3b/4 ANNEXA™-4 trial of AndexXa™ (andexanet alfa), a Factor Xa...